Cargando…

Urinary sodium evaluation: the missing target for diuretic treatment optimization in acute heart failure patients? Reply

Detalles Bibliográficos
Autores principales:	Damman, Kevin, Ter Maaten, Jozine M., van der Meer, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd. 2020
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687141/ https://www.ncbi.nlm.nih.gov/pubmed/32298523 http://dx.doi.org/10.1002/ejhf.1825

Ejemplares similares

Natriuresis-guided diuretic therapy in acute heart failure: a pragmatic randomized trial
por: ter Maaten, Jozine M., et al.
Publicado: (2023)

Clinical importance of urinary sodium excretion in acute heart failure
por: Damman, Kevin, et al.
Publicado: (2020)

Natriuresis‐guided therapy in acute heart failure: rationale and design of the Pragmatic Urinary Sodium‐based treatment algoritHm in Acute Heart Failure (PUSH‐AHF) trial
por: ter Maaten, Jozine M., et al.
Publicado: (2022)

Early treatment with tolvaptan improves diuretic response in acute heart failure with renal dysfunction
por: Matsue, Yuya, et al.
Publicado: (2017)

Effects of empagliflozin on renal sodium and glucose handling in patients with acute heart failure
por: Boorsma, Eva M., et al.
Publicado: (2020)

A combined clinical and biomarker approach to predict diuretic response in acute heart failure
por: ter Maaten, Jozine M., et al.
Publicado: (2015)

Diuretic dosing in heart failure: more data are needed
por: De Vecchis, Renato, et al.
Publicado: (2018)

Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction
por: ter Maaten, Jozine M., et al.
Publicado: (2020)

Worsening renal function in acute heart failure in the context of diuretic response
por: Emmens, Johanna E., et al.
Publicado: (2021)

Outcomes Associated With a Strategy of Adjuvant Metolazone or High‐Dose Loop Diuretics in Acute Decompensated Heart Failure: A Propensity Analysis
por: Brisco‐Bacik, Meredith A., et al.
Publicado: (2018)

Spot Urinary Sodium as a Biomarker of Diuretic Response in Acute Heart Failure
por: Oliva‐Damaso, Nestor, et al.
Publicado: (2023)

Fibroblast growth factor 23 mediates the association between iron deficiency and mortality in worsening heart failure
por: van der Wal, Haye H., et al.
Publicado: (2020)

Optimal diuretic strategies in heart failure
por: Suri, Sarabjeet S., et al.
Publicado: (2021)

Effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on potassium handling in patients with acute heart failure
por: Beusekamp, Joost C., et al.
Publicado: (2021)

Reply: Salt, Diuretics, and Obstructive Sleep Apnea
por: Giatti, Soraya
Publicado: (2021)

The value of spot urinary creatinine as a marker of muscle wasting in patients with new‐onset or worsening heart failure
por: Pandhi, Paloma, et al.
Publicado: (2021)

Dipeptidyl peptidase 3, a marker of the antagonist pathway of the renin–angiotensin–aldosterone system in patients with heart failure
por: Boorsma, Eva M., et al.
Publicado: (2021)

Proenkephalin and the risk of new‐onset heart failure: data from prevention of renal and vascular end‐stage disease
por: Emmens, Johanna E., et al.
Publicado: (2021)

Clinical implications of low estimated protein intake in patients with heart failure
por: Streng, Koen W., et al.
Publicado: (2022)

Diuretic Resistance in Heart Failure
por: Gupta, Richa, et al.
Publicado: (2019)

Reply: Sacubitril/valsartan for Chagas' heart disease heart failure?
por: Bocchi, Edimar Alcides, et al.
Publicado: (2018)

Innovation in Diuretic Therapy: The Missing Ingredient for Treating Worsening Heart Failure Outside the Hospital?
por: Greene, Stephen J., et al.
Publicado: (2018)

Reply: Perspectives and Limitations of the Studies of the Association Between Heart Failure and Cancer
por: Bertero, Edoardo, et al.
Publicado: (2022)

Subcutaneous Furosemide in Heart Failure: Pharmacokinetic Characteristics of a Newly Buffered Solution
por: Sica, Domenic A., et al.
Publicado: (2018)

Reply: Missing ligand model in autologous stem cell transplantation
por: Leung, W, et al.
Publicado: (2008)

Chlorthalidone, not hydrochlorothiazide, is the right diuretic for comparison
por: Mehta, Ravi Tejraj, et al.
Publicado: (2018)

Letter – Diuretics in primary hypertension – Reloaded
por: Gupta, Rahul
Publicado: (2017)

Letter – Diuretics in primary hypertension – Reloaded
por: Thanikgaivasan, Viginesh
Publicado: (2017)

Adrenomedullin in heart failure: pathophysiology and therapeutic application
por: Voors, Adriaan A., et al.
Publicado: (2018)

Diuretics as pathogenetic treatment for heart failure
por: Guglin, Maya
Publicado: (2011)

Diuretic Resistance Associated With Heart Failure
por: Shams, Elham, et al.
Publicado: (2022)

Response to: Use of prior odds for missing persons identifications - authors' reply
por: Budowle, Bruce, et al.
Publicado: (2012)

Reply: Early Recognition of Amyloid Cardiomyopathy: Potential and Need Before the Onset of Decompensated Heart Failure
por: Arora, Sameer, et al.
Publicado: (2021)

The Potential Role of Torsemide in Optimizing Loop Diuretic Therapy for Heart Failure Patients
por: Chopra, V. K, et al.
Publicado: (2023)

Acute Effects of Preventing Heart Failure by Sodium-Glucose Cotransporter 2 Inhibitors
por: Yanai, Hidekatsu
Publicado: (2021)

Sodium‐glucose cotransporter 2 inhibitors in heart failure with chronic kidney disease
por: Kato, Shingo, et al.
Publicado: (2022)

Length of hospital stay, diuretic dosing, and regression strategies
por: Çinier, Göksel, et al.
Publicado: (2019)

Role of Diuretics and Ultrafiltration in Congestive Heart Failure
por: Shchekochikhin, Dmitry, et al.
Publicado: (2013)

The Diuretic Effect of Theocalcin in Congestive Heart Failure
Publicado: (1931)

Reply to ‘Sexual function of patients with heart failure: distinct phenotypes distinct sexual function?’ by Konstantinos Koutsampasopoulos
por: Jaarsma, Tiny
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hc47vnf6lvlanrjisfl8anrsg8